Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5547664 | 0.81 | BRD4 (0.55) | KDM4EALDH1A1CYP3A4MAPTALOX15 | |
| SCHEMBL2183040 | 0.80 | ESR2 (0.51) | KDM4EALDH1A1CYP3A4MAPTALOX15 | |
| SCHEMBL13475983 | 0.80 | ACHE (0.40) | ALDH1A1BRD4CREBBP | |
| SCHEMBL14449384 | 0.80 | ACHE (0.40) | ALDH1A1BRD4CREBBP | |
| SCHEMBL2182284 | 0.78 | KDM4E (0.47) | KDM4EALDH1A1CYP3A4MAPTALOX15 | |
| SCHEMBL7840132 | 0.74 | ESR1 (0.42) | KDM4EALDH1A1CYP3A4MAPTALOX15 | |
| SCHEMBL5548009 | 0.74 | MEN1 (0.46) | KDM4EALDH1A1CYP3A4MAPTALOX15 | |
| SCHEMBL3796779 | 0.74 | CHRNB4 (0.50) | CYP3A4ESR1ESR2TTR | |
| SCHEMBL8504530 | 0.73 | CHRM2 (0.41) | BRD4CREBBPGABRA1GABRB2 | |
| SCHEMBL18350079 | 0.72 | DRD2 (0.50) | KDM4EALDH1A1CYP3A4MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127399-A1 | BIOSOURCED COMPOUND HAVING EPOXIDE FUNCTIONS, METHOD FOR THE SYNTHESIS OF SUCH A COMPOUND, AND USE THEREOF FOR PRODUCING EPOXY RESIN | AGRONOMIQUE INST NAT RECH (FR) | 2018-05-10 | — | — | US | disclosed |
| EP-0230475-B1 | NOVEL UREA DERIVATIVES, PROCESSES FOR PRODUCTION THEREOF AND HERBICIDE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-4838924-A | NONPHYTOTOXIC | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127399-A1 | BIOSOURCED COMPOUND HAVING EPOXIDE FUNCTIONS, METHOD FOR THE SYNTHESIS OF SUCH A COMPOUND, AND USE THEREOF FOR PRODUCING EPOXY RESIN | SRM, ODC1, PCNA | KDM4E 1364/4885ALDH1A1 816/4885CYP3A4 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.